Income Tax Expense (Benefit) in USD of DEXCOM INC from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
DEXCOM INC quarterly/annual Income Tax Expense (Benefit) history and change rate from 2010 to Q3 2025.
  • DEXCOM INC Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $68.5M, a 60% increase year-over-year.
  • DEXCOM INC Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $238M, a 278% increase year-over-year.
  • DEXCOM INC annual Income Tax Expense (Benefit) for 2024 was $133M, a 21.4% decline from 2023.
  • DEXCOM INC annual Income Tax Expense (Benefit) for 2023 was $169M, a 241% increase from 2022.
  • DEXCOM INC annual Income Tax Expense (Benefit) for 2022 was $49.6M, a 24.3% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

DEXCOM INC Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $238M $68.5M +$25.7M +60% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $213M $61.3M +$17M +38.4% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025
Q1 2025 $196M $48.9M +$62.8M 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $133M $59.6M +$69.7M 01 Oct 2024 31 Dec 2024 10-K 18 Feb 2025
Q3 2024 $63.1M $42.8M -$76.9M -64.2% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 $140M $44.3M +$900K +2.07% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025
Q1 2024 $139M -$13.9M -$29.8M -187% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 $169M -$10.1M -$51.5M -124% 01 Oct 2023 31 Dec 2023 10-K 18 Feb 2025
Q3 2023 $220M $120M +$74.7M +166% 01 Jul 2023 30 Sep 2023 10-Q 24 Oct 2024
Q2 2023 $146M $43.4M +$19M +77.9% 01 Apr 2023 30 Jun 2023 10-Q 25 Jul 2024
Q1 2023 $127M $15.9M +$77.1M 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024
Q4 2022 $49.6M $41.4M +$29.7M +254% 01 Oct 2022 31 Dec 2022 10-K 18 Feb 2025
Q3 2022 $19.9M $45M +$20.3M +82.2% 01 Jul 2022 30 Sep 2022 10-Q 26 Oct 2023
Q2 2022 -$400K $24.4M +$5.7M +30.5% 01 Apr 2022 30 Jun 2022 10-Q 27 Jul 2023
Q1 2022 -$6.1M -$61.2M -$46M -303% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023
Q4 2021 $39.9M $11.7M +$269M 01 Oct 2021 31 Dec 2021 10-K 08 Feb 2024
Q3 2021 -$229M $24.7M +$21.8M +752% 01 Jul 2021 30 Sep 2021 10-Q 27 Oct 2022
Q2 2021 -$251M $18.7M +$18.8M 01 Apr 2021 30 Jun 2021 10-Q 28 Jul 2022
Q1 2021 -$270M -$15.2M -$17.7M -708% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022
Q4 2020 -$252M -$257M -$259M -16169% 01 Oct 2020 31 Dec 2020 10-K 09 Feb 2023
Q3 2020 $6.9M $2.9M +$2.9M 01 Jul 2020 30 Sep 2020 10-Q 28 Oct 2021
Q2 2020 $4M -$100K -$1.3M -108% 01 Apr 2020 30 Jun 2020 10-Q 29 Jul 2021
Q1 2020 $5.3M $2.5M +$2.2M +733% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021
Q4 2019 $3.1M $1.6M -$1.2M -42.9% 01 Oct 2019 31 Dec 2019 10-K 14 Feb 2022
Q3 2019 $4.3M $0 +$1.8M 01 Jul 2019 30 Sep 2019 10-Q 27 Oct 2020
Q2 2019 $2.5M $1.2M +$1.8M 01 Apr 2019 30 Jun 2019 10-Q 28 Jul 2020
Q1 2019 $700K $300K +$100K +50% 01 Jan 2019 31 Mar 2019 10-Q 28 Apr 2020
Q4 2018 $600K $2.8M +$1.2M +75% 01 Oct 2018 31 Dec 2018 10-K 11 Feb 2021
Q3 2018 -$600K -$1.8M -$1.3M -260% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019
Q2 2018 $700K -$600K +$16.7M +96.5% 01 Apr 2018 30 Jun 2018 10-Q 31 Jul 2019
Q1 2018 -$16M $200K -$1.2M -85.7% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019
Q4 2017 -$14.8M $1.6M +$1.2M +300% 01 Oct 2017 31 Dec 2017 10-K 21 Feb 2019
Q3 2017 -$16M -$500K -$700K -350% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018
Q2 2017 -$15.3M -$17.3M -$17.4M -17400% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018
Q1 2017 $2.1M $1.4M +$1.4M 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018
Q4 2016 $700K $400K 01 Oct 2016 31 Dec 2016 10-K 21 Feb 2019
Q3 2016 $200K +$200K 01 Jul 2016 30 Sep 2016 10-Q 01 Nov 2017
Q2 2016 $100K +$100K 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2017
Q1 2016 $0 01 Jan 2016 31 Mar 2016 10-Q 02 May 2017
Q3 2015 $0 01 Jul 2015 30 Sep 2015 10-Q 01 Nov 2016
Q2 2015 $0 01 Apr 2015 30 Jun 2015 10-Q 02 Aug 2016
Q4 2013 $0 $0 $0 01 Oct 2013 31 Dec 2013 10-K 23 Feb 2016
Q3 2013 $0 $0 $0 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2013
Q2 2013 $0 $0 $0 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2013
Q1 2013 $0 $0 +$1.3M 01 Jan 2013 31 Mar 2013 10-Q 01 May 2013
Q4 2012 -$1.3M $0 $0 01 Oct 2012 31 Dec 2012 10-K 25 Feb 2015
Q3 2012 -$1.3M $0 $0 01 Jul 2012 30 Sep 2012 10-Q 06 Nov 2013
Q2 2012 -$1.3M $0 $0 01 Apr 2012 30 Jun 2012 10-Q 07 Aug 2013
Q1 2012 -$1.3M -$1.3M -$1.3M 01 Jan 2012 31 Mar 2012 10-Q 07 Aug 2013
Q4 2011 $0 $0 01 Oct 2011 31 Dec 2011 10-K 20 Feb 2014
Q3 2011 $0 01 Jul 2011 30 Sep 2011 10-Q 01 Nov 2012
Q2 2011 $0 01 Apr 2011 30 Jun 2011 10-Q 06 Aug 2012
Q1 2011 $0 01 Jan 2011 31 Mar 2011 10-Q 02 May 2012

DEXCOM INC Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $133M -$36.1M -21.4% 01 Jan 2024 31 Dec 2024 10-K 18 Feb 2025
2023 $169M +$119M +241% 01 Jan 2023 31 Dec 2023 10-K 18 Feb 2025
2022 $49.6M +$9.7M +24.3% 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025
2021 $39.9M +$292M 01 Jan 2021 31 Dec 2021 10-K 08 Feb 2024
2020 -$252M -$255M -8223% 01 Jan 2020 31 Dec 2020 10-K 09 Feb 2023
2019 $3.1M +$2.5M +417% 01 Jan 2019 31 Dec 2019 10-K 14 Feb 2022
2018 $600K -$1M -62.5% 01 Jan 2018 31 Dec 2018 10-K 11 Feb 2021
2017 $1.6M +$900K +129% 01 Jan 2017 31 Dec 2017 10-K 13 Feb 2020
2016 $700K +$600K +600% 01 Jan 2016 31 Dec 2016 10-K 21 Feb 2019
2015 $100K $0 0% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018
2014 $100K +$100K 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017
2013 $0 +$1.3M 01 Jan 2013 31 Dec 2013 10-K 23 Feb 2016
2012 -$1.3M -$1.3M 01 Jan 2012 31 Dec 2012 10-K 25 Feb 2015
2011 $0 $0 01 Jan 2011 31 Dec 2011 10-K 20 Feb 2014
2010 $0 01 Jan 2010 31 Dec 2010 10-K 21 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.